This Article Full Text (PDF) All Versions of this Article: 38/1/1    most recent 01.STR.0000251674.14708.9bv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carod-Artal, F. J. Search for Related Content PubMed PubMed Citation Articles by Carod-Artal, F. J. Pubmed/NCBI databases Medline Plus Health Information Stroke Related Collections Health policy and outcome research Behavioral/psychosocial - stroke Behavioral Changes and Stroke Epidemiology Related Article

(Stroke. 2007;38:1.)
© 2007 American Heart Association, Inc.

Editorials

Are Mood Disorders a Stroke Risk Factor?

Francisco Javier Carod-Artal, MD, PhD

From the Department of Neurology, The Sarah Network of Rehabilitation Hospitals, Sarah Hospital, Brasilia DF, Brazil.

Correspondence to Prof Francisco Javier Carod-Artal, MD, PhD, Neurology Department, The Sarah Network of Rehabilitation Hospitals, Sarah Hospital, SMHS quadra 501 conjunto A, CEP 7330-150, Brasilia DF, Brazil. E-mail javier{at}sarah.br or fjavier4644@terra.com.br

See related article, pages 16–21

Key Words: depression • epidemiology • risk factors • stroke

A growing body of evidence suggests that biological mechanisms underlie a bidirectional link between depression and many neurological illnesses, and that mood disorders can affect the course of the diseases.¹ Depression commonly occurs after a stroke, with an estimated prevalence as high as 30% in the first year after the event.² It is well known that poststroke depression affects quality of life, functional recovery, cognitive function and health care use in stroke survivors.³ Inversely, does any association exist between a history of a previous affective disorder and future risk of cardiovascular events? Recent prospective studies have shown an association between depression and incidence of hypertension,^4,5 coronary heart disease,^6,7 and cardiovascular mortality.^8–11

In the Multiple Risk Factor Intervention Trial, 12 866 men were followed for 18 years; those with greater depressive symptoms, as measured by the Center for Epidemiologic Studies Depression Scale (CES-D), were associated with a significant higher risk of cardiovascular mortality (hazard ratio=1.21; 95% CI, 1.03 to 1.41; P<0.05) and stroke mortality (hazard ratio= 2.03; 95% CI, 1.20 to 3.44; P<0.01).¹² The NHANES I Epidemiologic Study¹³ showed that individuals reporting 5 or more symptoms of depression at baseline were 50% more likely to die of a stroke-related cause during a 29-year follow-up.

The Baltimore Epidemiologic Catchment Area Study showed that individuals with a history of depressive disorder, measured with the diagnostic interview schedule, were 2.6 times more likely to report stroke.¹⁴ Depressive symptoms, measured by the Zung Self-rating Depression Scale, were also associated with an increased incidence of ischemic stroke in a Japanese 10-year follow study.¹⁵ Self-reported depression scores significantly predicted stroke in an Australian cohort of people 60 years and older followed for >8 years.¹⁶ Significant psychological distress, as measured by the 30-item General Health Questionnaire, was also a predictor of fatal ischemic stroke in the Caerphilly Study (relative risk 3.36; 95% CI, 1.29 to 8.71).¹⁷

The study by Salaycik et al¹⁸ in this issue of Stroke provides some new insights to the association between mood disorders and risk of ischemic stroke in young and middle-aged people. They conducted a prospective study on 4120 Framingham Heart Study participants, using up to 8 years of follow-up. The CES-D was used to measure depressive symptoms. In this community-based study, depressive symptoms were an independent risk factor for incident stroke/transient ischemic attack in people <65 years. Additionally, the risk of developing stroke/transient ischemic attack was 4.21 times greater in those individuals with symptoms of depression. After adjusting for traditional vascular risk factors (hazard ratio=3.43; 95% CI, 1.60 to 7.36; P=0.002) and education (hazard ratio=4.89, 95% CI, 2.19 to 10.95) similar results were obtained.

Pathogenic Mechanisms

How can we explain this association? Several mechanisms have been proposed to explain the increased risk of cardiovascular disease in depressed patients^19–22: (1) sympathoadrenal hyperactivity; (2) diminished heart rate variability; (3) ventricular instability; (4) biological markers, including platelet activation and inflammatory proteins; (5) myocardial ischemia reaction to mental stress. However, the mechanisms by which depressive symptoms may increase the risk of stroke have not been fully elucidated.

It is possible that depressive symptoms may be associated with stroke through the development of hypertension because it has been reported that depressive symptoms predicted later hypertension incidence.^4,5 Some authors have considered the association of depressive symptoms and later onset of ischemic stroke an epiphenomenon because late-life depression may have a vascular basis. According to the vascular depression hypothesis, small-vessel disease secondary to hypertension or diabetes may disrupt frontal-subcortical circuits and generate depressive symptoms.²³

Depression may also increase the risk of ischemic stroke through increased platelet aggregation.²⁴ Mean plasma levels of platelet factor 4 and β-thromboglobulin were reported to be higher in depressed patients with ischemic heart disease than in nondepressed patients with ischemic heart disease and healthy controls.²⁵ Selective serotonin reuptake inhibitors are known to inhibit platelet activity. Treatment with selective serotonin reuptake inhibitors in depressed postacute coronary syndrome patients has been associated with reductions in platelet/endothelial activation.²⁶

Finally, depressive symptomatology may also be associated with a higher prevalence of other modifiable lifestyle risk factors, such as smoking²⁷ and lower levels of physical activity.²⁸ Behavioral factors, although potential cofounders, do not seem to attenuate the association between depression and stroke incidence.

Methodological issues

Several methodological issues warrant discussion. The question whether depression, depressive symptoms or depressive scores on self-rating questionnaires are associated with risk of stroke is clinically relevant. Most studies that analyzed the link between depression and stroke used self-rating scales. Furthermore, they did not confirm the clinical diagnosis of depression by using a psychiatric structured interview or the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria. The criteria for the diagnosis of a depressive episode should include at least 2 weeks of depressed mood, loss of interest, or diminished sense of pleasure plus 4 of 7 other features that are sufficient to cause clinically important psychological or physical distress or functional impairment.²⁹

Pre- and poststroke depression are generic terms. For example, differential diagnosis of poststroke depression should include the pseudodepressive manifestations of strategic infarctions (apathy, aprosody, lack of self psychic activation syndrome, pathological crying, and frontal disexecutive syndrome).³⁰ Many epidemiological studies that have focused on depression as a risk factor for stroke only screened "depressive symptoms". It should be convenient to evaluate a wider spectrum of affective disorders (first major depressive disorder, refractory and chronic depression, atypical depression, bipolar disorder), anxiety disorders and a variety of mental conditions including stress, coping and adjustment reactions, and even subjective emotional well-being. In addition, 10% to 30% of persons with a major depressive episode recover incompletely and have persistent, residual depressive symptoms, called dysthymia. The symptoms of this disorder are similar to those of major depression but last longer and are milder.³¹

The influence of complications of the mood disorders, such as suicide risk, and important comorbidities, including alcoholism and substance-abuse should be addressed. Other psychosocial factors including social network, psychological status, and personal characteristics may confound the relation between depressive scores and risk of stroke, and should also be analyzed more deeply in further studies.

Psychometric properties of self-rating and/or evaluator-rating scales for depression should be evaluated. Although the CES-D has been the most frequently used self-rating scale and has adequate internal consistency and reliability, other questionnaires have not proven it yet. Briefly, the process of validation and analysis of the metric properties of a self-rating versus evaluator-rating scale should include the following: acceptability (floor and ceiling effects), scaling assumptions (item-total correlation), reliability (internal consistency assessed by using Cronbach’s ; test-retest reliability for individual items assessed by means of weighted ; test- retest reliability for total scores assessed by means of an intraclass correlation coefficient), construct validity and convergent validity.

Clinical Implications

Which are the clinical implications of an association between mood disorders and stroke incidence in individuals below 65 years? May it be suggested that any reduction in depressive symptoms in those patients at above average stroke risk might potentially result in a corresponding decline in stroke incidence and mortality? Caution is urged because we need to improve and confirm the diagnosis of affective disorders.

Do these data suggest that identification and treatment of depressive symptoms at younger ages may have an impact on the primary prevention of stroke? We need more evidences to propose, as a stroke primary prevention strategy, the prevention and treatment of mood disorders. This situation can be compared with literature regarding poststroke depression therapy because the effectiveness of early initiation of antidepressants in the prevention of poststroke depression is not clear.³² However, the life-long nature of many of the mood disorders, their elevated risk of recurrence and the existence of a wide range of treatments (depression-specific psychotherapies, cognitive therapy and pharmacotherapy), are supporting facts for their prevention, early recognition and treatment.^33,34

The results of this interesting study from the Framingham Heart Study investigators raise more questions, and further studies will be necessary to analyze the association between affective disorders and specific ischemic and hemorrhagic stroke subtypes. According to proposed pathogenic mechanisms, an association between mood disorders and atherosclerotic and lacunar stroke subtypes could be hypothesized. Stroke severity, recurrence, mortality, and ethnicity should be studied in specific neuropsychiatric diagnostic categories through standardized measures. The strength of this association among minority populations has not been fully analyzed. Finally, changes in depression severity over time, rather than baseline depression, might also be predictive of cardiovascular events and should be further evaluated.

Acknowledgments

Disclosures

None.

Footnotes

The opinions in this editorial are not necessarily those of the editors or of the American Heart Association.

References

1. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, Nemeroff CB, Bremner JD, Carney RM, Coyne JC, Delong MR, Frasure-Smith N, Glassman AH, Gold PW, Grant I, Gwyther L, Ironson G, Johnson RL, Kanner AM, Katon WJ, Kaufmann PG, Keefe FJ, Ketter T, Laughren TP, Leserman J, Lyketsos CG, McDonald WM, McEwen BS, Miller AH, Musselman D, O’Connor C, Petitto JM, Pollock BG, Robinson RG, Roose SP, Rowland J, Sheline Y, Sheps DS, Simon G, Spiegel D, Stunkard A, Sunderland T, Tibbits P Jr, Valvo WJ. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005; 58: 175–189.[CrossRef][Medline] [Order article via Infotrieve]
2. Carod Artal FJ. Post-stroke depression (I). Epidemiology, diagnostic criteria and risk factors. Rev Neurol. 2006; 42: 169–175.[Medline] [Order article via Infotrieve]
3. Carod-Artal J, Egido JA, Gonzalez JL, Varela de Seijas E. Quality of life among stroke survivors evaluated 1 year after stroke: experience of a stroke unit. Stroke. 2000; 31: 2995–3000.[Abstract/Free Full Text]
4. Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Fam Med. 1997; 6: 43–49.[Abstract]
5. Davidson K, Jonas BS, Dixon KE, Markovitz JH. Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study? Arch Intern Med. 2000; 160: 1495–1500.[Abstract/Free Full Text]
6. Ford DE, Mead LA, Shane PP, Cooper-Patrick L, Wang N-Y, Klag MJ. Depression is a risk factor for coronary artery disease in men: the Precursors Study. Arch Intern Med. 1998; 158: 1422–1426.[Abstract/Free Full Text]
7. Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML. Depression as an antecedent to heart disease among women and men in the NHANES I Study. Arch Intern Med. 2000; 160: 1261–1268.[Abstract/Free Full Text]
8. Ariyo AA, Haan M, Tangen CM, Rutledge JC, Cushman M, Dobs A, Furberg CD. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Circulation. 2000; 102: 1773–1779.[Abstract/Free Full Text]
9. Penninx BWJH, Beekman ATF, Honig A, Deeg DJH, Schoevers RA, van Eijk JTM, van Tilburg W. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry. 2001; 58: 221–227.[Abstract/Free Full Text]
10. Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Cochrane B, Robbins J, Aragaki A, Dunbar-Jacob J. Depression and cardiovascular sequelae in postmenopausal women. Arch Intern Med. 2004; 164: 289–298.[Abstract/Free Full Text]
11. Everson SA, Roberts RE, Goldberg DE, Kaplan GA. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med. 1998; 158: 1133–1138.[Abstract/Free Full Text]
12. Gump BB, Matthews KA, Eberly LE, Chang YF; for the MRFIT Research Group. Depressive symptoms and mortality in men: results from the Multiple Risk Factor Intervention Trial. Stroke. 2005; 36: 98–102.[Abstract/Free Full Text]
13. Jonas BS, Mussolino ME. Symptoms of depression as a prospective risk factor for stroke. Psychosom Med. 2000; 62: 463–471.[Abstract/Free Full Text]
14. Larson SL, Owens PL, Ford D, Eaton W. Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore Epidemiologic Catchment Area study. Stroke. 2001; 32: 1979–1983.[Abstract/Free Full Text]
15. Ohira T, Iso H, Satoh S, Sankai T, Tanigawa T, Ogawa Y, Imano H, Sato S, Kitamura A, Shimamoto T. Prospective study of depressive symptoms and risk of stroke among Japanese. Stroke. 2001; 32: 903–908.[Abstract/Free Full Text]
16. Simons LA, McCallum J, Friedlander Y, Simons J. Risk factors for ischemic stroke: Dubbo Study of the Elderly. Stroke. 1998; 29: 1341–1346.[Abstract/Free Full Text]
17. May M, McCarron P, Stansfeld S, Ben-Shlomo Y, Gallacher J, Yarnell J, Davey Smith G. Does psychological distress predict the risk of ischemic stroke and transient ischemic attack? The Caerphilly Study. Stroke. 2002; 33: 7–12.[Abstract/Free Full Text]
18. Salaycik KJ, Kelly-Hayes M, Beiser A, Nguyen AH, Brady S, Kase CS, Wolf PA. Depressive symptoms and risk of stroke: the Framingham Study. Stroke. 2007; 38: 16–21.
19. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998; 55: 580–592.[Abstract/Free Full Text]
20. Jiang W, Krishnan RRK, O’Connor CM. Depression and heart disease: evidence of a link, and its therapeutic implications. CNS Drugs. 2002; 16: 111–127.[CrossRef][Medline] [Order article via Infotrieve]
21. Ladwig KH, Marten-Mittag B, Lowel H, Doring A, Koenig W; MONICA-KORA Augsburg Cohort Study 1984–1998. C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984–1998. Eur Heart J. 2005; 26: 2537–2542.[Abstract/Free Full Text]
22. Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets JB, Haas B, Evans A, Jouven X, Ducimetiere P; PRIME Study Group. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation. 2005; 111: 2299–2305.[Abstract/Free Full Text]
23. Alexopoulos GS, Meyers B, Young R, Campbell S, Silbersweig D, Charlson M. "Vascular depression" hypothesis. Arch Gen Psychiatry. 1997; 54: 915–923.[Abstract]
24. Musselman DL, Tomer A, Manatunga AK, Knight BT, Porter MR, Kasey S, Marzec U, Harker LA, Nemeroff CB. Exaggerated platelet reactivity in major depression. Am J Psychiatry. 1996; 153: 1313–1317.[Abstract/Free Full Text]
25. Laghrissi-Thode F, Wagner WR, Pollock BG, Johnson PC, Finkel MS. Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry. 1997; 42: 290–295.[CrossRef][Medline] [Order article via Infotrieve]
26. Serebruany VL, Glassman AH, Malinin AI, Nemeroff CB, Musselman DL, van Zyl LT, Finkel MS, Krishnan KR, Gaffney M, Harrison W, Califf RM, O’Connor CM; Sertraline AntiDepressant Heart Attack Randomized Trial Study Group. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation. 2003; 108: 939–944.[Abstract/Free Full Text]
27. Camacho TC, Roberts RE, Lazarus NB, Kaplan GA, Cohen RD. Physical activity and depression: evidence from the Alameda County Study. Am J Epidemiol. 1991; 134: 220–231.[Abstract/Free Full Text]
28. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. Depression and the dynamics of smoking: a national perspective. JAMA. 1990; 264: 1541–1545.[Abstract]
29. Diagnostic and statistical manual for mental disorders, 4th ed: DSM-IV. Washington, DC: American Psychiatric Association, 1994.
30. Carod-Artal FJ. Post-stroke depression (II): its differential diagnosis, complications and treatment. Rev Neurol. 2006; 42: 238–244.[Medline] [Order article via Infotrieve]
31. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Paulus MP, Kunovac JL, Leon AC, Mueller TI, Rice JA, Keller MB. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry. 1998; 55: 694–700.[Abstract/Free Full Text]
32. Bhogal SK, Teasell R, Foley N, Speechley M. Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression. J Am Geriatr Soc. 2005; 53: 1051–1057.[CrossRef][Medline] [Order article via Infotrieve]
33. Keller MB, Lavori PW, Rice J, Coryell W, Hirschfeld RM. The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: a prospective follow-up. Am J Psychiatry. 1986; 143: 24–28.[Abstract/Free Full Text]
34. Mann JJ. Drug therapy: the medical management of depression. N Engl J Med. 2005; 353: 1819–1834.[Free Full Text]

Related Article:

Depressive Symptoms and Risk of Stroke: The Framingham Study

Kimberly J. Salaycik, Margaret Kelly-Hayes, Alexa Beiser, Anh-Hoa Nguyen, Stephen M. Brady, Carlos S. Kase, and Philip A. Wolf
Stroke 2007 38: 16-21. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				M J Bos, T Linden, P J Koudstaal, A Hofman, I Skoog, M M B Breteler, and H Tiemeier Depressive symptoms and risk of stroke: the Rotterdam Study J. Neurol. Neurosurg. Psychiatry, September 1, 2008; 79(9): 997 - 1001. [Abstract] [Full Text] [PDF]

				P. G. Surtees, N.W.J. Wainwright, R. N. Luben, N. J. Wareham, S. A. Bingham, and K.-T Khaw Psychological distress, major depressive disorder, and risk of stroke Neurology, March 4, 2008; 70(10): 788 - 794. [Abstract] [Full Text] [PDF]

				W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 29, 2008; 117(4): e25 - e146. [Full Text] [PDF]

				J. Nuyen, P. M. Spreeuwenberg, P. P. Groenewegen, G. A.M. van den Bos, and F. G. Schellevis Impact of Preexisting Depression on Length of Stay and Discharge Destination Among Patients Hospitalized for Acute Stroke: Linked Register-Based Study Stroke, January 1, 2008; 39(1): 132 - 138. [Abstract] [Full Text] [PDF]

				J. A. Levy and G. J. Chelune Cognitive-Behavioral Profiles of Neurodegenerative Dementias: Beyond Alzheimer's Disease J Geriatr Psychiatry Neurol, December 1, 2007; 20(4): 227 - 238. [Abstract] [PDF]

				Is Depression an Independent Risk Factor for Stroke? Journal Watch Neurology, March 27, 2007; 2007(327): 3 - 3. [Full Text]

This Article Full Text (PDF) All Versions of this Article: 38/1/1    most recent 01.STR.0000251674.14708.9bv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carod-Artal, F. J. Search for Related Content PubMed PubMed Citation Articles by Carod-Artal, F. J. Pubmed/NCBI databases Medline Plus Health Information Stroke Related Collections Health policy and outcome research Behavioral/psychosocial - stroke Behavioral Changes and Stroke Epidemiology Related Article